Table 3 Significant and suggestive lead SNPs from the cross-ancestry GWAS meta-analysis of the Million Veteran Program and Indivior cohorts.

From: Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response

Chromosome

Position

SNP

P value

Nearest Gene

2

196279963

rs149319538

2.66 × 10–08

AC064834.1

11

114180814

rs2852445

6.60 × 10–07

NNMT

6

122683440

rs9401519

7.36 × 10–07

RNU1-18P

6

54294688

rs669917

1.55 × 10–06

CLNS1AP1

8

130043829

rs6470688

1.70 × 10–06

LINC00977

6

54695917

rs12215138

2.22 × 10–06

RP11-524H19.2

9

71905345

rs147697343

2.37 × 10–06

FAM189A2

6

54365478

rs573501000

4.16 × 10–06

CLNS1AP1

13

111459167

rs72663484

4.23 × 10–06

LINC00567

13

102667059

rs60776232

5.00 × 10–06

FGF14

2

153461929

rs66706786

5.21 × 10–06

FMNL2

1

2563901

rs147506475

6.47 × 10–06

MMEL1

10

14767985

rs113072550

6.50 × 10–06

FAM107B

17

29691368

rs2057769

7.72 × 10–06

NF1

16

83173960

rs9932942

9.50 × 10–06

CDH13

4

179359799

rs72706653

9.81 × 10–06

RNA5SP173

  1. The genome-wide significant SNP is bolded.
  2. SNP single nucleotide polymorphism.